Prevalence of Antiretroviral Drug Resistance Mutations in Chronically HIV-Infected, Treatment-Naive Patients: Implications for Routine Resistance Screening before Initiation of Antiretroviral Therapy | Zendy

Richard M. Novak | Zendy; L. Chen | Zendy; Rodger D. MacArthur | Zendy; John D. Baxter | Zendy; Katherine Huppler Hullsiek | Zendy; Grace Peng | Zendy; Ying Xiang | Zendy; Christopher Henely | Zendy; Barry Schmetter | Zendy; J. Uy | Zendy; Mary van den Berg-Wolf | Zendy; Michael J. Kozal | Zendy

Open Access

Prevalence of Antiretroviral Drug Resistance Mutations in Chronically HIV-Infected, Treatment-Naive Patients: Implications for Routine Resistance Screening before Initiation of Antiretroviral Therapy

Author(s) -

Richard M. Novak,

L. Chen,

Rodger D. MacArthur,

John D. Baxter,

Katherine Huppler Hullsiek,

Grace Peng,

Ying Xiang,

Christopher Henely,

Barry Schmetter,

J. Uy,

Mary van den Berg-Wolf,

Michael J. Kozal

Publication year - 2005

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/427212

Subject(s) - medicine , drug resistance , resistance mutation , hiv drug resistance , confidence interval , reverse transcriptase , virology , logistic regression , drug naïve , reverse transcriptase inhibitor , immunology , viral load , sida , viral disease , virus , drug , antiretroviral therapy , polymerase chain reaction , gene , pharmacology , biology , genetics

The prevalence of drug resistance among persons with newly acquired human immunodeficiency virus (HIV) infection is well documented. However, it is unclear to what extent these mutations persist in chronically infected, treatment-naive patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research